Publications by authors named "Laslo Roman"

Claim this Profile
E
Efficacy of Neoadjuvant Therapy With Cisplatin Plus Mitomycin C in BRCA1-Mutated Ovarian Cancer.
Tatyana V Gorodnova, Khristina B Kotiv, Alexandr O Ivantsov, Olga N Mikheyeva, Galina I Mikhailiuk, Laslo D Roman

Int J Gynecol Cancer· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of H. pylori Infection and Atrophic Gastritis in a Population-based Screening with Serum Biomarker Panel (GastroPanel®) in St. Petersburg.
Laslo D Roman, Ruslan Lukyanchuk, Oleg A Sablin, Elena I Araslanova, Carita Eklund

Anticancer Res· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of KRAS/NRAS Mutations in a Phase III Study of Panitumumab with FOLFIRI Compared with FOLFIRI Alone as Second-line Treatment for Metastatic Colorectal Cancer.
Marc Peeters, Kelly S Oliner, Timothy J Price, Andrés Cervantes, Alberto F Sobrero, Laslo Roman

Clin Cancer Res· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fluorouracil, leucovorin, and irinotecan plus either sunitinib or placebo in metastatic colorectal cancer: a randomized, phase III trial.
Alfredo Carrato, Anna Swieboda-Sadlej, Marzanna Staszewska-Skurczynska, Robert Lim, Laslo Roman

J Clin Oncol· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer.
José Baselga, Javier Cortés, Sung-Bae Kim, Seock-Ah Im, Roberto Hegg, Laslo Roman

N Engl J Med· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial.
Luca Gianni, Tadeusz Pienkowski, Young-Hyuck Im, Laslo Roman, Ling-Ming Tseng

Lancet Oncol· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized phase III study of panitumumab with fluorouracil, leucovorin, and irinotecan (FOLFIRI) compared with FOLFIRI alone as second-line treatment in patients with metastatic colorectal cancer.
Marc Peeters, Timothy Jay Price, Andrés Cervantes, Alberto F Sobrero, Michel Ducreux, Laslo Roman

J Clin Oncol· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis